SCHEMBL20007956

SCHEMBL20007956

CC1(N)CCB(C#N)CC1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20008099 0.76 — —
SCHEMBL71836 0.67 — —
SCHEMBL21287273 0.67 — —
SCHEMBL24181925 0.66 — —
SCHEMBL21287454 0.66 — —
SCHEMBL25105535 0.66 — —
SCHEMBL21088130 0.65 — —
Hydrochloric Acid SCHEMBL8308716 0.64 — —
Hydrochloric Acid SCHEMBL457944 0.64 — —
SCHEMBL3106063 0.64 ALDH1A1 (0.43) ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515916-B1 SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS INC (US) 2023-06-07 — — EP disclosed
WO-2018057884-A1 SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2018-03-29 — — WO disclosed
Send feedback